跳至主要内容
临床试验/CTRI/2018/07/014958
CTRI/2018/07/014958招募中未知

Evaluation of the benifit of luteal phase administration of gonadotropin releasing hormone (GnRH) agonist on patients undergoing in vitro fertilisation (IVF) / intracytoplasmic sperm injection â?? randomised open label trial

Bangalore Baptist Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Infertile couples undergoing IVF/ICSI with their own gametes
  • 2. Age above 20 years
  • 3. Willing to provide valid written informed consent
  • 4. Antagonist protocol
  • 5. rhCG ovulation trigger
  • 6. Fresh embryo transfer with at least one embryo available for transfer, with not more than 3 embryos transferred at a time, with their consent

排除标准

  • 1. Age greater than 40 years
  • 2. Women on GnRH agonist therapy for controlled ovarian hyperstimulation
  • 3. Prior history of recurrent implantation failure
  • 4. Patients at a high risk of ovarian hyperstimulation syndrome (OHSS)
  • 5. Patients with hydrosalpinx / other uterine anatomical abnormalities (bicornuate uterus, septate uterus etc.)

研究者

相似试验